Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders
Weight gain and the associated increased risk of diabetes and cardiovascular disease may be problems for individuals who receive long-term treatment with atypical antipsychotics. Atypical antipsychotics differ in their propensity to cause obesity and other metabolic disturbances. If a patient gains substantial weight while taking atypical antipsychotics, the physician should consider switching him or her to a drug with a lower risk of weight gain. The physician should also address patient lifestyle issues such as poor diet and lack of exercise.
/div>
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders
Vol 86 • 2025 • Number 1
Read the Current Issue
Original Research
Psychological Support in Psychedelic Therapy
Original Research
Long-Term Safety and Efficacy of Esmethadone in MDD
Original Research
Suicidal Behaviors and Obstructive Sleep Apnea
Editorial
A Collaborative Endeavor
Brief Report
Sex Differences in PTSD among US Military Veterans
Clinical and Practical Psychopharmacology